Internal Medicine, Infectious Disease · Oklahoma City, OK
NPI
1457343402
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
4221 S Western Ave, #4010
Oklahoma City, OK, 73109
Phone (405) 644-6464
Groups this clinician bills Medicare through
Medicare paid, 2024
$633K
371,417 services
Medicare patients, 2024
722
Average age 71
Drug cost, 2024
$2.4M
3,868 prescriptions
Company payments, 2025
$667
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David H Chansolme was code J0878 (injection, daptomycin, 1 mg), 350,763 times for 35 patients. In total David H Chansolme billed 371,417 services in 52 codes, and Medicare paid $633K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 350,763 | 35 | $0.02 | $7,291 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 1,208 | 16 | $0.35 | $426 |
| 96365 Intravenous Infusion, Hydration | Office | 817 | 60 | $44.36 | $36K |
| 99232 Hospital E&M - Subsequent | Facility | 788 | 328 | $58.65 | $46K |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 626 | 23 | $6.79 | $4,250 |
| 99214 Office E&M - Established | Office | 478 | 295 | $86.33 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 392 | 267 | $12.29 | $4,818 |
| 99233 Hospital E&M - Subsequent | Facility | 370 | 129 | $87.45 | $32K |
| 99223 Hospital E&M - Initial | Facility | 288 | 244 | $126.55 | $36K |
| 99211 Office E&M - Established | Office | 181 | 57 | $16.15 | $2,922 |
| 96366 Intravenous Infusion, Hydration | Office | 133 | 16 | $14.63 | $1,946 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 59 | 32 | $78.55 | $4,634 |
| 99215 Office E&M - Established | Office | 54 | 36 | $124.60 | $6,728 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 41 | 39 | $39.62 | $1,624 |
| 99204 Office E&M - New | Office | 34 | 34 | $124.65 | $4,238 |
By year: 2022 $658K for 175,822 services; 2023 $575K for 101,492 services; 2024 $633K for 371,417 services.
Medicare prescription drug claims, 2024
In 2024, the drug David H Chansolme prescribed most often to Medicare patients was Daptomycin, with 412 prescriptions and refills. In total David H Chansolme wrote 3,868 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 412 | 412 | 69 | $205K |
| Doxycycline Hyclate Generic | 345 | 454 | 72 | $12K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 335 | 462 | 71 | $5,451 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 251 | 255 | 26 | $1.0M |
| Vancomycin Hcl Generic | 220 | 220 | 42 | $37K |
| Ceftriaxone Ceftriaxone Sodium | 180 | 180 | 37 | $12K |
| Ciprofloxacin Hcl Generic | 180 | 221 | 41 | $4,862 |
| Cefazolin Sodium Generic | 148 | 148 | 29 | $13K |
| Ertapenem Ertapenem Sodium | 116 | 116 | 30 | $42K |
| Fluconazole Generic | 104 | 112 | 30 | $3,114 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 89 | 89 | Under 11 | $345K |
| Cephalexin Generic | 80 | 102 | 14 | $1,351 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 78 | 78 | 16 | $15K |
| Ritonavir Generic | 71 | 79 | Under 11 | $6,838 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 53 | 53 | Under 11 | $4,832 |
Brand drugs: 596 claims; generic drugs: 3,272 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David H Chansolme $667 ($667 in general payments such as food, travel and fees) from 8 companies. The largest payer was Insmed, Inc. with $215.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.